Author Topic: (AAN) TG Therapeutics presents data from ULTIMATE I and II Phase 3 trials of Briumvi  (Read 29 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest

From Yahoo Finance (April 25) a report from the annual AAN conference currently in progress (April 23-27), "TG Therapeutics Announces Presentation of Data from the ULTIMATE I and II Phase 3 Trials of BRIUMVI (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting":


https://finance.yahoo.com/news/tg-therapeutics-announces-presentation-data-120000179.html



MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
278 Views
Last post November 30, 2013, 08:04:56 pm
by agate
1 Replies
304 Views
Last post June 03, 2020, 02:57:56 pm
by agate
3 Replies
41 Views
Last post February 28, 2023, 04:31:39 pm
by agate
0 Replies
30 Views
Last post March 20, 2023, 09:35:24 pm
by agate
0 Replies
7 Views
Last post January 10, 2024, 09:32:15 pm
by agate